(Hypertension. 1996;28:472-477.)
© 1996 American Heart Association, Inc.
Articles |
Angiotensin II in the Evolution of Experimental Heart Failure
the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, and Immunochemical Core Laboratory (J.E.B.), Mayo Clinic and Foundation, Rochester, Minn.
Correspondence to Andreas Luchner, MD, Cardiorenal Research Laboratory, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905. E-mail luchner.andreas@mayo.edu.
Although angiotensin II (Ang II) has been implicated in the pathophysiology of congestive heart failure, its temporal and regional changes during the development and progression of the disease are poorly defined. Our objective was to assess circulating, renal, cardiac, and vascular Ang II in a canine model of rapid ventricular pacing–induced heart failure that evolves from early left ventricular dysfunction to overt congestive heart failure. Ang II was measured by radioimmunoassay with low cross-reactivity to other angiotensins. Control, early left ventricular dysfunction, and overt congestive heart failure dogs were studied. Early left ventricular dysfunction was characterized by impaired cardiac function, cardiac enlargement, preserved renal perfusion pressure, maintained urinary sodium excretion, and normal plasma renin activity. Overt congestive heart failure was characterized by further impaired cardiac function and cardiac enlargement, reduced renal perfusion pressure, urinary sodium retention, and increased plasma renin activity and plasma Ang II. In early left ventricular dysfunction dogs, renal cortical, renal medullary, ventricular, and aortic Ang II were unchanged, and atrial Ang II was decreased. In overt congestive heart failure dogs, Ang II was increased in the kidney and heart compared with normal dogs and in all tissues compared with early left ventricular dysfunction dogs. The greatest increase in tissue Ang II occurred in the renal medulla. We conclude that early increases in local renal, myocardial, and vascular Ang II do not occur in this model of early left ventricular dysfunction and may even be suppressed. In contrast, increased myocardial and particularly renal Ang II in association with increased circulating Ang II are hallmarks of overt experimental congestive heart failure. These studies provide new insights into the temporal and regional alterations in Ang II during the progression of experimental congestive heart failure.
Key Words: heart failure • natriuretic peptides • heart • kidney • aorta
This article has been cited by other articles:
 |
|
 |
|
  T. M. Mousa, D. Liu, K. G. Cornish, and I. H. Zucker Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure J Appl Physiol, March 1, 2008; 104(3): 616 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Ahmed, E. Oie, L. E. Vinge, T. G. von Lueder, T. Attramadal, and H. Attramadal Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling Cardiovasc Res, May 1, 2007; 74(2): 323 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Armoundas, J. Rose, R. Aggarwal, B. D. Stuyvers, B. O'Rourke, D. A. Kass, E. Marban, S. R. Shorofsky, G. F. Tomaselli, and C. William Balke Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1607 - H1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Schirger, H. H. Chen, M. Jougasaki, O. Lisy, G. Boerrigter, A. Cataliotti, and J. C. Burnett Jr Endothelin A Receptor Antagonism in Experimental Congestive Heart Failure Results in Augmentation of the Renin-Angiotensin System and Sustained Sodium Retention Circulation, January 20, 2004; 109(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-P. Li, S.-R. Chen, and H.-L. Pan Angiotensin II Stimulates Spinally Projecting Paraventricular Neurons through Presynaptic Disinhibition J. Neurosci., June 15, 2003; 23(12): 5041 - 5049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsumoto, A. Wada, T. Tsutamoto, M. Ohnishi, T. Isono, and M. Kinoshita Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure Circulation, May 27, 2003; 107(20): 2555 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Chen, M. M. Redfield, L. J. Nordstrom, A. Cataliotti, and J. C. Burnett Jr. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure Am J Physiol Renal Physiol, May 1, 2003; 284(5): F1115 - F1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Paolocci, T. Katori, H. C. Champion, M. E. St. John, K. M. Miranda, J. M. Fukuto, D. A. Wink, and D. A. Kass From the Cover: Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: Independence from beta -adrenergic signaling PNAS, April 29, 2003; 100(9): 5537 - 5542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Albage, G. Kenneback, J. van der Linden, and H. Berglund Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure Ann. Thorac. Surg., March 1, 2003; 75(3): 790 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Vittorio, C. C. Lang, S. D. Katz, M. Packer, D. M. Mancini, and U. P. Jorde Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving {beta}-Blockers Circulation, January 21, 2003; 107(2): 290 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nakamura, K. Egashira, Y. Machida, S. Hayashidani, M. Takeya, H. Utsumi, H. Tsutsui, and A. Takeshita Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure: Roles of Oxidative Stress and Inflammation Circulation, July 16, 2002; 106(3): 362 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuruda, M. Jougasaki, G. Boerrigter, B. K. Huntley, H. H. Chen, A. B. D'Assoro, S. C. Lee, A. M. Larsen, A. Cataliotti, and J. C. Burnett Jr Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor Circ. Res., February 8, 2002; 90(2): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luchner, F. Muders, O. Dietl, E. Friedrich, F. Blumberg, A.A. Protter, G.A.J. Riegger, and D. Elsner Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction Cardiovasc Res, August 15, 2001; 51(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Chen, J. G. Lainchbury, Y. Matsuda, G. J. Harty, and J. C. Burnett Jr Endogenous Natriuretic Peptides Participate in Renal and Humoral Actions of Acute Vasopeptidase Inhibition in Experimental Mild Heart Failure Hypertension, August 1, 2001; 38(2): 187 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y.T. Hart, D. M. Meyer, H. D. Tazelaar, J. P. Grande, J. C. Burnett Jr, P. R. Housmans, and M. M. Redfield Load Versus Humoral Activation in the Genesis of Early Hypertensive Heart Disease Circulation, July 10, 2001; 104(2): 215 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hisaoka, M. Yano, T. Ohkusa, M. Suetsugu, K. Ono, M. Kohno, J. Yamada, S. Kobayashi, M. Kohno, and M. Matsuzaki Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure Cardiovasc Res, February 1, 2001; 49(2): 319 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arimura, K. Egashira, R. Nakamura, T. Ide, H. Tsutsui, H. Shimokawa, and A. Takeshita Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H68 - H75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Luchner, D. D. Borgeson, J. A. Grantham, E. Friedrich, G. A.J. Riegger, J. C. Burnett Jr, and M. M. Redfield Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dog Eur J Heart Fail, December 1, 2000; 2(4): 379 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Liu, S. Irvine, I. A. Reid, K. P. Patel, and I. H. Zucker Chronic Exercise Reduces Sympathetic Nerve Activity in Rabbits With Pacing-Induced Heart Failure : A Role for Angiotensin II Circulation, October 10, 2000; 102(15): 1854 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Luchner, M. Jougasaki, E. Friedrich, D. D. Borgeson, T. L. Stevens, M. M. Redfield, G. A. J. Riegger, and J. C. Burnett Jr. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R974 - R979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Solter, D. Sisson, W. Thomas, and L. Goetze Intrarenal Effects of Ecadotril during Acute Volume Expansion in Dogs with Congestive Heart Failure J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 989 - 995. [Abstract] [Full Text]
|
|
|
|
|
|
H. Senzaki, N. Paolocci, Y. A. Gluzband, M. L. Lindsey, J. S. Janicki, M. T. Crow, and D. A. Kass {beta}-Blockade Prevents Sustained Metalloproteinase Activation and Diastolic Stiffening Induced by Angiotensin II Combined With Evolving Cardiac Dysfunction Circ. Res., April 14, 2000; 86(7): 807 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Liu, X.-P. Yang, D. Mehta, M. Bulagannawar, G. M. Scicli, and O. A. Carretero Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H507 - H514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Lainchbury, J. C. Burnett Jr., D. Meyer, and M. M. Redfield Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H33 - H40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Dostal and K. M. Baker The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function? Circ. Res., October 1, 1999; 85(7): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luchner, T. L. Stevens, D. D. Borgeson, M. Redfield, C.-M. Wei, J. G. Porter, and J. C. Burnett Jr. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1684 - H1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cornelius, S. R. Holmer, F. U. Muller, G. A. J. Riegger, and H. Schunkert Regulation of the Rat Atrial Natriuretic Peptide Gene After Acute Imposition of Left Ventricular Pressure Overload Hypertension, December 1, 1997; 30(6): 1348 - 1355. [Abstract] [Full Text]
|
|
|
|
|
|
M. Jougasaki, T. L. Stevens, D. D. Borgeson, A. Luchner, M. M. Redfield, and J. C. Burnett Jr. Adrenomedullin in experimental congestive heart failure: cardiorenal activation Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1392 - R1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsuruda, M. Jougasaki, G. Boerrigter, B. K. Huntley, H. H. Chen, A. B. D'Assoro, S. C. Lee, A. M. Larsen, A. Cataliotti, and J. C. Burnett Jr Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor Circ. Res., February 8, 2002; 90(2): 128 - 134. [Abstract] [Full Text] [PDF]
|
|